BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GBMA - ECPv6.15.12.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GBMA
X-ORIGINAL-URL:https://gbma.com.au
X-WR-CALDESC:Events for GBMA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251103
DTEND;VALUE=DATE:20251108
DTSTAMP:20260404T043116
CREATED:20250710T043836Z
LAST-MODIFIED:20251001T035824Z
UID:7998-1762128000-1762559999@gbma.com.au
SUMMARY:Global Biosimilars Week\, 3 - 7 November 2025
DESCRIPTION:On behalf of the International Generic and Biosimilar Medicines Association (IGBA)\, the GBMA is pleased to officially announce that the 6th Annual Global Biosimilars Week social media awareness campaign will take place from November 3 to 7\, 2025.  \nThis year’s theme is Biosimilars: A Wise Investment for Global Health – better access to biosimilar medicines will help more people live healthier lives worldwide. \nWe warmly invite all stakeholders in Australia to show their support of biosimilars throughout the week by using the hashtags #GlobalBiosimilarsWeek and #GBW25. \nTo support participation\, a social media toolkit is available for download with campaign logos\, customisable image templates\, sample posts and other resources.  Please note that because this is an international resource\, some of the messaging may need tailoring to ensure they are appropriate for the Australian market.  \n\nGlobal Webinar – Wed 5th November\nAs the world faces increasing health challenges\, biosimilar medicines offer a promising solution to enhance accessibility\, affordability\, and sustainability of healthcare systems worldwide\, which are all important pillars to meet the UN Sustainable Development Goals for Health by 2030 \n \nTo learn more\, visit the IGBA’s global site: Global Biosimilars Week 2025 \nQuestions? Please reach out to the GBMA via our ‘Contact us’ page.
URL:https://gbma.com.au/event/global-biosimilars-week-3-7-november-2025/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260204T093000
DTEND;TZID=Australia/Sydney:20260204T140000
DTSTAMP:20260404T043117
CREATED:20260304T000746Z
LAST-MODIFIED:20260304T000746Z
UID:8389-1770197400-1770213600@gbma.com.au
SUMMARY:GBMA Summit - No patient left waiting: end the era of medicine shortages
DESCRIPTION:Thank you to everyone who attended the recent GBMA Summit – No patient left waiting: ending the era of medicine shortages \nGovernment\, industry and healthcare leaders came together at the GBMA Summit to explore some of the contributors to medicine shortages and discuss how healthcare stakeholders can together chart a path toward sustainable access to medicines for Australians. \nThe program opened with key insights to set the context for the day\, including global perspectives and keynote addresses from the Minister for Health\, Disability and Ageing The Hon. Mark Butler MP and Shadow Minister for Health and Aged Care Senator the Hon. Anne Ruston\, before moving through three focused sessions. \n\nSession 1: Barriers\, examining how Australia’s reimbursement settings can contribute to unintended disruptions;\nSession 2: Opportunity and agility\, exploring globally informed\, action-oriented solutions for effective reporting and stronger system responsiveness; and\nSession 3: Access and processes\, identifying practical reforms to streamline regulation without compromising safety.\n\nConfirmed speakers: \n\nThe Hon. Mark Butler MP\, Minister for Health\, Disability and Ageing\nSenator the Hon. Anne Ruston\, Shadow Minister for Health and Aged Care\nHon. Prof. Jane Halton AO PSM\, Independent Chair\, GBMA\nMarnie Peterson\, Chief Executive Officer\, GBMA\nAssoc. Prof. Tom Simpson\, President\, Adpha\nLuke Escombe\, Ambassador for Crohn’s and Colitis Australia\nHayley Tamborini\, Chief Commercial Officer\, Arrotex\nClint Holland\, Country Head\, Sandoz\nSteve Graham\, General Manger\, Commercial (Business Development)\, DBG Health\nDr Stephen Jenkins\, Director Government & Corporate Affairs APAC\, Teva Pharma\nSue MacLeman\, Chair and Non-Executive Director\, Medicines Australia\nNick Henderson\, First Assistant Secretary\, Medicines Regulation Division\, TGA\nElizabeth Cuming\, Chief Executive Officer\, NPSA\nAnthony Tassone\, Victoria Branch Vice President & National Councilor\, The Pharmacy Guild of Australia\nChad Rieger\, Head of Medical Affairs and Policy\, Australia and New Zealand\, Sandoz\nFleur Douy\, Senior Regulatory Affairs Manager\, Arrotex\nChris Campbell\, General Manager Policy and Program Delivery\, PSA
URL:https://gbma.com.au/event/gbma-summit-no-patient-left-waiting-end-the-era-of-medicine-shortages/
LOCATION:Parliament House\, Australia
ATTACH;FMTTYPE=image/jpeg:https://gbma.com.au/wp-content/uploads/2026/03/20260204_143050.jpg
END:VEVENT
END:VCALENDAR